Chemring Group PLC

Director's Dealing • Jan 23, 2020

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7860A

Chemring Group PLC

23 January 2020

23 January 2020

Chemring Group PLC

PDMR share dealing

Chemring Group PLC ("Chemring" or "the Company") announces that Sarah Ellard, a director of the Company, sold 29,182 ordinary 1p shares in the capital of the Company on 22 January 2020, of which 15,722 ordinary 1p shares were sold to satisfy the tax and national insurance liability arising on a deferred share award which vested on 19 January 2020. Following this transaction, Mrs Ellard holds 68,820 ordinary 1p shares in the capital of the Company.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Sarah Ellard

2

Reason for the notification

a)

Position/status

Director/PDMR

b)

Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Chemring Group PLC

b)

LEI

213800U9A54VQJ5P2J41

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

1p ordinary shares

GB00B45C9X44

b)

Nature of the transaction

Sale of shares

c)

Price(s) and volume(s)

Price(s)	Volume(s)
266.7p	29,182

d)

Aggregated information

- Aggregated volume

- Price

e)

Date of the transaction

22 January 2020

f)

Place of the transaction

UK

For further information:

Chemring Group PLC
Sarah Ellard	Group Legal Director	+44 (0)1794 833 901

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHFLFLDLRIVFII